The Phase I/II study will enrol approximately 368 adults aged 18 years and above.

Paine Schwartz Partners–backed HGS BioScience, Jacksonville, Flordia, a leading provider of biological crop solutions, ...

Twist Bioscience (TWST) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports ...

Global phase 1/2 clinical trial initiated for GBP511, a vaccine targeting the Sarbecovirus FamilyNext-generation vaccine leveraging SKYCovione's recombinant protein-based platform and nanoparticle ...

BOULDER — Think Bioscience Inc. recently raised an oversubscribed $55 million Series A round. Think Bioscience Inc. recently raised an oversubscribed $55 million Series A round.

In a recent interview, Robert Fried, CEO of Niagen Bioscience, delves into the science of aging and the pivotal role of a molecule known as NAD (nicotinamide adenine dinucleotide). He explains how NAD ...

Automated Twist NGS library preparation workflows available on SPT Labtech’s firefly platform via the firefly cloud ...

In the longevity and wellness space, Niagen Bioscience is charting a course defined by both scientific rigor and an unwavering commitment to responsible innovation Niagen Bioscience (NASDAQ: NAGE, ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Harvard Bioscience has yet another leadership shakeup as the Holliston-based biotech firm’s CEO is set to retire and two new members have been added to its board of directors in an attempt to regain ...

On Thursday, Skye Bioscience Inc. (NASDAQ:SKYE) reported positive results from two preclinical obesity studies testing nimacimab, a peripherally-acting CB1-inhibiting monoclonal antibody. In the first ...